Veterinary Medicines

Gafervit injekčný roztok

Authorised
  • Porcine normal immunoglobulin
  • Iron dextran
  • Thiamine hydrochloride
  • Riboflavin
  • Pyridoxine hydrochloride
  • Nicotinamide
  • Calcium pantothenate
  • Copper chloride
  • Cobalt(II) chloride
Download as PDF

Product identification

Medicine name:
Gafervit injekčný roztok
Active substance:
  • Porcine normal immunoglobulin
  • Iron dextran
  • Thiamine hydrochloride
  • Riboflavin
  • Pyridoxine hydrochloride
  • Nicotinamide
  • Calcium pantothenate
  • Copper chloride
  • Cobalt(II) chloride
Target species:
  • Pig (piglet)
  • Pig (suckling piglet)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Porcine normal immunoglobulin
    5000.00
    milligram(s)
    /
    100.00
    millilitre(s)
  • Iron dextran
    700.00
    milligram(s)
    /
    100.00
    millilitre(s)
  • Thiamine hydrochloride
    3.00
    milligram(s)
    /
    100.00
    millilitre(s)
  • Riboflavin
    1.14
    milligram(s)
    /
    100.00
    millilitre(s)
  • Pyridoxine hydrochloride
    0.28
    milligram(s)
    /
    100.00
    millilitre(s)
  • Nicotinamide
    42.84
    milligram(s)
    /
    100.00
    millilitre(s)
  • Calcium pantothenate
    1.60
    milligram(s)
    /
    100.00
    millilitre(s)
  • Copper chloride
    2.71
    milligram(s)
    /
    100.00
    millilitre(s)
  • Cobalt(II) chloride
    0.27
    milligram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig (piglet)
      • All relevant tissues
        0
        day
    • Pig (suckling piglet)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB03AE10
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/396/91-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 15/12/2021
Download